The Effect of Time-Slot Scheduling on Flu Vaccination Rates
NCT ID: NCT01206686
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50000 participants
INTERVENTIONAL
2009-09-30
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates
NCT01207232
Collaborative Efforts to Increase Flu Vaccination
NCT01403649
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
NCT04590066
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates
NCT04565353
Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
NCT05493787
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 Hour Planning Prompt
Planning Prompt
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
2 Hour Planning Prompt
Planning Prompt
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
1 Day Planning Prompt
Planning Prompt
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
Default Planning Prompt
Default Appointment
Patients were given a suggested date and time for receiving a flu shot.
Control
Control
Patients were provided with basic information (present in all conditions) about when and where they could receive a flu shot, but they were given no further treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Planning Prompt
Patients were prompted to write down a planned date (and in some cases time) for receiving a flu shot.
Default Appointment
Patients were given a suggested date and time for receiving a flu shot.
Control
Patients were provided with basic information (present in all conditions) about when and where they could receive a flu shot, but they were given no further treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* employees of partner corporations executing study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard University
OTHER
Yale University
OTHER
Stanford University
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine L Milkman, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
810589
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.